Form 8-K - Current report:
SEC Accession No. 0001193125-26-260671
Filing Date
2026-06-08
Accepted
2026-06-08 07:11:42
Documents
11
Period of Report
2026-06-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sptx-20260608.htm   iXBRL 8-K 48311
2 EX-99.1 sptx-ex99_1.htm EX-99.1 139235
3 GRAPHIC img130682148_0.gif GRAPHIC 6063
  Complete submission text file 0001193125-26-260671.txt   323749

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sptx-20260608.xsd EX-101.SCH 26953
14 EXTRACTED XBRL INSTANCE DOCUMENT sptx-20260608_htm.xml XML 5120
Mailing Address 6 TIDE STREET SUITE 400 BOSTON MA 02110
Business Address 6 TIDE STREET SUITE 400 BOSTON MA 02110 617-807-4062
Seaport Therapeutics, Inc. (Filer) CIK: 0002042347 (see all company filings)

EIN.: 992235719 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-43254 | Film No.: 261071009
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)